gabexate has been researched along with Nephrosis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, J | 1 |
| Suzuki, S | 1 |
| Nozawa, R | 1 |
| Kumaki, S | 1 |
| Kume, K | 1 |
| Higuchi, E | 1 |
| Kamiyama, S | 1 |
| Ohara, N | 1 |
| Yugeta, E | 1 |
| Kato, K | 1 |
1 other study available for gabexate and Nephrosis
| Article | Year |
|---|---|
Effect of camostat mesilate on puromycin aminonucleoside nephrotic rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Esters; Gabexate; Guanidines; Male; Nephrosis; Protease Inhib | 1988 |